Prosecution Insights
Last updated: August 17, 2026

Examiner: RAYMOND, LINNAE ELIZABETH

Tech Center 3700 • Art Units: 3781

This examiner grants 50% of resolved cases

Performance Statistics

50.4%
Allow Rate
-19.6% vs TC avg
167
Total Applications
+59.3%
Interview Lift
1237
Avg Prosecution Days
Based on 113 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
13.2%
§102 Novelty
57.3%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18826425 CONTINUOUS SUCTION AND REPERFUSION MECHANISM Non-Final OA Boston Scientific Medical Device Limited
18910418 ENDOLUMINAL TREATMENT SYSTEMS, DEVICES, AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18978059 ABSORBENT ARTICLES WITH FRANGIBLE PATHWAYS COMPRISING LINES OF WEAKNESS WITH FREE FIBER ENDS Non-Final OA The Procter & Gamble Company
18967768 ABSORBENT ARTICLES WITH FRANGIBLE PATHWAYS COMPRISING VARIOUS TENSILE STRENGTHS Non-Final OA The Procter & Gamble Company
18632582 ABSORBENT ARTICLE WITH FRONT AND/OR BACK WAIST REGIONS HAVING A HIGH-STRETCH ZONE AND A LOW-STRETCH ZONE AND METHODS FOR MAKING Final Rejection The Procter & Gamble Company
17953364 ABSORBENT ARTICLE WITH LAMINATE BOND PATTERN Non-Final OA The Procter & Gamble Company
17875471 PANT-TYPE ABSORBENT ARTICLE Final Rejection The Procter & Gamble Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month